Opportunities to use EHR-derived RWE to inform HTA decision-making

Applications

Real-world evidence generated from an EHR has been shown to be more relevant, timely, and representative for health technology appraisals (HTA) compared to evidence from clinical trials. In this session, use cases demonstrating the value of using RWE in the HTA setting will be showcased as well as an opportunity to discuss the role of RWE with NICE.

Register for this session

June 17, 2021

11:00am – 12:00pm ET

Live Q&A

Speakers

Blythe Adamson Headshot

Blythe Adamson, PhD, MPH

Principal Quantitative Scientist

Flatiron Health

pall_jonsson_01

Páll Jónsson, PhD

Programme Director - Data

National Institute for Health and Care Excellence (NICE)

scott_ramsey_02

Scott Ramsey, MD, PhD

Director, Hutchinson Institute for Cancer Outcomes Research

Fred Hutchinson Cancer Center

Akshay-Swaminathan-02

Akshay Swaminathan

Senior Quantitative Data Analyst

Flatiron Health

danielleBargo_02

Danielle Bargo, MSc (Moderator)

Head of HTA Program Development

Flatiron Health

Join the live presentations and discussions.
Register for ResearchX